Stay updated on Safety of PBCAR20A in NHL/CLL Clinical Trial
Sign up to get notified when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.

Latest updates to the Safety of PBCAR20A in NHL/CLL Clinical Trial page
- Check5 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision advances from v3.7.1 to v3.7.2. The page itself continues to display a 403 error.SummaryDifference1%

- Check33 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 error.SummaryDifference0.2%

- Check47 days agoChange DetectedA 403 Forbidden error page is now shown instead of the study details, indicating an access issue rather than new or updated study information.SummaryDifference20%

- Check54 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0. This update reflects an internal version bump rather than changes to the study content or user-facing information.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, representing a small update to the study record rather than a substantive change to the study details.SummaryDifference0.1%

Stay in the know with updates to Safety of PBCAR20A in NHL/CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.